Decoding chemical profiles and biological activities of aerial parts and roots of eryngium thorifolium boiss by HPLC-MS/MS, GC-MS and in vitro chemical assays
Göster/ Aç
Erişim
info:eu-repo/semantics/embargoedAccessTarih
2024Yazar
Zengin, GökhanYagi, Sakina
Eldahshan, Omayma A.
Singab, Abdel Nasser
Selvi, Selami
Rodrigues, Maria J.
Custodio, Luisa
Dall'Acqua, Stefano
Üst veri
Tüm öğe kaydını gösterÖzet
Eryngium species are widely distributed and primarily utilised for medicinal and culinary purposes. This study
aimed to evaluate the chemical composition, antioxidant, enzyme inhibition, and cytotoxic properties of various
extracts from the aerial parts and roots of E. thorifolium Boiss. The chemical composition of ethyl acetate,
methanol, and water extracts was analysed using High-Performance Liquid Chromatography-Electrospray Ioni
zation Tandem Mass Spectrometry (HPLC-ESI-MS/MS), while the hexane ones were examined using Gas
Chromatography-Mass Spectrometry (GC-MS) analysis. The most predominant class of secondary metabolites
identified were fatty acid amides and flavonoids as hexose conjugates. Extracts from the aerial parts exhibited the
highest antioxidant activity, with the methanol and water extracts showing the best anti- 2,2-diphenyl-1-picryl
hydrazyl (DPPH) (21.9 mg trolox equivalent (TE)/g) and anti- 2,2′-Azino-bis(3-ethylbenzothiazoline-6-sulfonic
acid) (ABTS) (89.26 mg TE/g) activities. Enzyme inhibition tests revealed that the hexane extract from the roots
had the highest anti-acetylcholinesterase activity (2.49 mg galantamine equivalent (GALAE)/g). Additionally,
both the hexane and ethyl acetate extracts from the aerial parts demonstrated the highest antibutyrylcholinesterase activity (3.13 and 3.71 mg GALAE/g, p ≥ 0.05). At a concentration of 100 μg/mL, all
extracts from the roots and aerial parts, except the water one, displayed potent cytotoxicity against the human
embryonic (HEK 293) and murine macrophages (RAW 264.7) cell lines, with cellular viability ranging from 1.66
to 2.62% compared to the control (0.5% DMSO) (89.2 and 95.1%, respectively). Through network pharmacology
and molecular docking, the phytochemicals of E. thorifolium show significant potential as natural compounds
targeting key proteins involved in cancer progression, including Bcl-2, c-KIT, PI3K, and AKT. Their binding af
finities and predicted interactions highlight their possible therapeutic applications in managing various cancers.
These findings suggested E. thorifolium is a promising source of phytochemicals targeting specific oxidative stresslinked diseases, including cancer, diabetes and neurodegenerative disorders.